公开(公告)号：US10772550B2

公开(公告)日：2020-09-15

申请号：US15466684

申请日：2017-03-22

Applicant: Intuity Medical, Inc.

Inventor： John Gregory Aceti ,  Sterling Eduard McBride ,  Richard Morgan Moroney, III ,  Christopher Carter Gregory ,  Peter John Zanzucchi

IPC: A61B5/00 ,  A61B5/15 ,  A61B5/145 ,  A61B5/1455 ,  A61B5/151 ,  A61B5/157 ,  A61M37/00 ,  G01N33/49 ,  A61B5/155

Abstract: The invention relates to analyte monitoring/drug (pharmaceutical agent) delivery device. The invention is suited for monitoring various blood constituents such as glucose. The device has a housing that at least partially encloses a plurality of microneedles disposed on a carrier and an electronics portion. Each microneedle is in fluid communication with a corresponding microchannel. Each microneedle is individually addressable. That is, each microneedle can be extended and retracted individually via an actuator. The electronics portion includes a processor and associated circuitry (e.g., memory, supporting electronics and the like), a motor or the like, a sensor, a power supply (e.g., battery) and optionally an interface. In general, the processor controls the operation of the device and is data communication with the actuator, motor, sensor and interface. The invention provides for autonomous operation, that is, without intervention of the user. The invention can optionally provide for calibration without intervention of the user. The invention can also provide for semi-continuous monitoring for day and night time. The invention can provide for up to four, or more, weeks of operation. The invention can provide for a device that is relative small in size, and therefore unobtrusive. The invention can also provide for device with remote control and interactive electronics. The invention may be also used for the delivery of various pharmaceutical agents including high potency drugs to minimize patient intervention and minimize discomfort.

公开(公告)号：US09603562B2

公开(公告)日：2017-03-28

申请号：US13669366

申请日：2012-11-05

Applicant: Intuity Medical, Inc.

Inventor： John Gregory Aceti ,  Sterling Eduard McBride ,  Richard Morgan Moroney, III ,  Christopher Carter Gregory ,  Peter John Zanzucchi

IPC: A61B5/15 ,  A61B5/157 ,  A61B5/145 ,  A61B5/1455 ,  A61B5/151 ,  A61B5/00 ,  A61M37/00 ,  G01N33/49 ,  A61B5/155

CPC classification number: A61B5/150984 ,  A61B5/1411 ,  A61B5/14514 ,  A61B5/14532 ,  A61B5/14546 ,  A61B5/1455 ,  A61B5/150022 ,  A61B5/150076 ,  A61B5/150213 ,  A61B5/150389 ,  A61B5/150503 ,  A61B5/150526 ,  A61B5/150755 ,  A61B5/15087 ,  A61B5/150969 ,  A61B5/15109 ,  A61B5/15119 ,  A61B5/15123 ,  A61B5/15146 ,  A61B5/15153 ,  A61B5/15163 ,  A61B5/155 ,  A61B5/157 ,  A61B5/681 ,  A61B5/6833 ,  A61B2560/0412 ,  A61B2560/0443 ,  A61M37/0015 ,  A61M2037/0023 ,  A61M2037/0038 ,  A61M2209/088 ,  A61M2230/201 ,  G01N33/491

Abstract: The invention relates to analyte monitoring/drug delivery device. The invention is suited for monitoring various blood constituents such as glucose. The device has a housing that at least partially encloses a plurality of microneedles disposed on a carrier and an electronics portion. Each microneedle is in fluid communication with a corresponding microchannel. Each microneedle is individually addressable. That is, each microneedle can be extended and retracted individually via an actuator. The invention can optionally provide for calibration without intervention of the user and can also provide for semi-continuous monitoring for day and night time. The invention can provide up to four, or more, weeks of operation. The invention can provide for a device that is relatively small in size, and therefore unobtrusive. The invention can also provide for device with remote control and interactive electronics. The invention may be also used for the delivery of various pharmaceutical agents.